Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aijaz Ahmed, MD
Stanford University
Principal Investigator - Arthur Berman, DO
Florida Center for Gastroenterology
Principal Investigator - Bruce Bacon, MD
St. Louis University Medical Center
Principal Investigator - Emmet B Keeffe, MD, MACP
Romark Laboratories L.C.
Study Director - Ira Jacobson, MD
New York Presbyterial-Weill Medical College of Cornell University
Principal InvestigatorKOL profile → - Joseph K Lim, MD
Yale University
Principal Investigator - Mitchell L Shiffman, MD
McGuire Veteran's Administration Medical Center
Principal InvestigatorKOL profile → - Ronald E Pruitt, MD
Nashville Medical Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Palo Alto Va Healthcare System
Palo Alto, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Bay Pines Va Healthcare System
Bay Pines, Florida, United States
- Florida Center for Gastroenterology
Largo, Florida, United States
- Atlanta Gastroenterology Associates
Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- New York Presbyterian-Weill Medical College of Cornell University
New York, New York, United States
- Nashville Medical Research Institute
Nashville, Tennessee, United States
- Metropolitan Research
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2008
- Primary completion
- 30 Apr 2010
- Completion
- 30 Apr 2010
- Last update posted
- 10 Feb 2014
- Registered enrollment
- 112
- Registry id
- NCT00637923
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.